Metsera calls Novo Nordisk $9.1bn proposal 'Superior'
MLex Summary: Metsera announced that its board of directors has declared an unsolicited proposal from Novo Nordisk for a total of approximately $9.1 billion to be a "Superior Company Proposal," as...To view the full article, register now.
Already a subscriber? Click here to view full article